IM Cannabis Corp. (IMCC)
| Market Cap | 1.63M -86.6% |
| Revenue (ttm) | 32.25M -12.6% |
| Net Income | -12.62M |
| EPS | -57.94 |
| Shares Out | 543.42K |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 23,973 |
| Open | 2.890 |
| Previous Close | 2.890 |
| Day's Range | 2.720 - 3.147 |
| 52-Week Range | 2.568 - 77.100 |
| Beta | 2.10 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 13, 2026 |
About IMCC
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
Financial Performance
In 2025, IM Cannabis's revenue was 54.73 million, an increase of 1.30% compared to the previous year's 54.03 million. Losses were -11.32 million, 6.93% more than in 2024.
Financial numbers in CAD Financial StatementsNews
IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
TORONTO and GLIL YAM, Israel, Sept. 2, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announce...
IM Cannabis Shares Commence Trading on 30:1 Consolidated Basis
TORONTO and GLIL YAM, Israel, Aug. 27, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that,...
IM Cannabis trading halted, news pending
19:50 EDT IM Cannabis (IMCC) trading halted, news pending
IM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance
TORONTO and GLIL YAM, Israel, Aug. 18, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that ...
IM Cannabis Enters into Agreement to Sell IMC Holdings and European- Focused Assets
Transaction Expected to Result in an Improvement of Approximately CAD$3 million in Shareholders' Equity TORONTO and GLIL YAM, Israel, Aug. 17, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Com...
IM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results
TORONTO and GLIL YAM, Israel, Aug. 13, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), today announced its financial results for the three and six months ended June 30,...
IM Cannabis Earnings release: Q2 2026
IM Cannabis released its Q2 2026 earnings on August 13, 2026, summarizing the period's financial results.
IM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note Financing
TORONTO and GLIL YAM, Israel, Aug. 7, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced ...
IM Cannabis Provides Corporate Update
TORONTO and GLIL YAM, Israel, July 27, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that ...
IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
TORONTO and GLIL YAM, Israel, July 1, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC), a medical cannabis company with operations in Israel and Germany, today announced ...
IM Cannabis signs LoI to sell European activities
IM Cannabis (IMCC) has entered into a non-binding letter of intent with Slil.com Holding Ltd., a privately-held Israeli entity beneficially owned and controlled by Oren Shuster, the company’s CEO, a…
IM Cannabis Corp. Enters into Letter of Intent to Sell its European Activities, Expects to Significantly Reduce Debt by CAD$10.5 million
Transaction Expected to Streamline Operations, Retain Israeli Business, Improve Working Capital through debt reduction and Cash Flow While Enabling the Pursuit of New Investment Opportunities as Previ...
IM Cannabis Announces Form F-3 Resale Registration Statement Filing
TORONTO and GLIL YAM, Israel, June 9, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that, ...
IM Cannabis registers to sell 17.28M common shares for holders
This filing relates to the offer and sale from time to time by the selling stockholder of up to 17.28M common shares. The company is not selling any shares under…
IM Cannabis Registration statement: Registration filing
IM Cannabis filed a registration statement on June 9, 2026, providing details about a securities offering with the SEC.
IM Cannabis Corp. Announces First Quarter 2026 Financial Results
TORONTO and GLIL YAM, Israel, May 13, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced ...
IM Cannabis Earnings release: Q1 2026
IM Cannabis released its Q1 2026 earnings on May 13, 2026, summarizing the period's financial results.
IM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings
TORONTO and GLIL YAM, Israel, May 7, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced t...
IMC Announces Receipt of Nasdaq Minimum Bid Price Notification
TORONTO and GLIL YAM, Israel, April 10, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announce...
IM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash Flow
TORONTO and GLIL YAM, Israel, March 31, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today reported...
IM Cannabis Earnings release: Q4 2025
IM Cannabis released its Q4 2025 earnings on March 30, 2026, summarizing the period's financial results.
IM Cannabis Annual report: Q4 2025
IM Cannabis has published its Q4 2025 annual report on March 30, 2026.
Avant Brands issues notice of termination for agreement with Adjupharm
Avant Brands (AVBTF)’ wholly-owned subsidiary, GreenTec Holdings, has issued a formal notice of termination for its Trademark Licensing Agreement with Adjupharm, a subsidiary of IM Cannabis (IMCC) Cor...
IM Cannabis enters non-binding LOI to acquire 51% of Blackaxe Technologies
IM Cannabis (IMCC) announced that, following its previous announcement regarding its decision to explore the introduction of additional business activities, it has entered into a non-binding letter of...
IMC Announces a Strategic Entry to the Cyber Drone Interception and Satellite Intelligence Markets by Signing a Non-Binding Agreement to Acquire 51% of Blackaxe Technologies
TORONTO and GLIL YAM, Israel, March 17, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC), a medical cannabis company with operations in Israel and Germany, today announce...